JP2012107046A5 - - Google Patents

Download PDF

Info

Publication number
JP2012107046A5
JP2012107046A5 JP2012035170A JP2012035170A JP2012107046A5 JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5 JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5
Authority
JP
Japan
Prior art keywords
olopatadine
polyvinylpyrrolidone
solution composition
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012035170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012107046A (ja
JP5328947B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012107046A publication Critical patent/JP2012107046A/ja
Publication of JP2012107046A5 publication Critical patent/JP2012107046A5/ja
Application granted granted Critical
Publication of JP5328947B2 publication Critical patent/JP5328947B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012035170A 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物 Expired - Lifetime JP5328947B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27
US60/301,315 2001-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010069010A Division JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013061887A Division JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Publications (3)

Publication Number Publication Date
JP2012107046A JP2012107046A (ja) 2012-06-07
JP2012107046A5 true JP2012107046A5 (OSRAM) 2013-05-09
JP5328947B2 JP5328947B2 (ja) 2013-10-30

Family

ID=23162841

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物
JP2012035170A Expired - Lifetime JP5328947B2 (ja) 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Country Status (20)

Country Link
US (2) US6995186B2 (OSRAM)
EP (1) EP1399127B1 (OSRAM)
JP (5) JP4827374B2 (OSRAM)
KR (1) KR100884711B1 (OSRAM)
CN (1) CN1211125C (OSRAM)
AR (1) AR034619A1 (OSRAM)
AT (1) ATE295149T1 (OSRAM)
AU (1) AU2002310461B2 (OSRAM)
BR (1) BRPI0210707B8 (OSRAM)
CA (1) CA2447924C (OSRAM)
DE (1) DE60204142T2 (OSRAM)
DK (1) DK1399127T3 (OSRAM)
ES (1) ES2238574T3 (OSRAM)
GC (1) GC0000397A (OSRAM)
MX (1) MXPA03011947A (OSRAM)
PL (1) PL205565B1 (OSRAM)
PT (1) PT1399127E (OSRAM)
TW (1) TWI231759B (OSRAM)
WO (1) WO2003002093A1 (OSRAM)
ZA (1) ZA200308771B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
US20070275853A1 (en) * 2004-04-08 2007-11-29 Kyowa Hakko Kogyo Co., Ltd. Solid Products with Improved Stability and Method for Producing the Same
JPWO2005102313A1 (ja) * 2004-04-21 2007-08-16 協和醗酵工業株式会社 慢性副鼻腔炎の予防および/または治療剤
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
SI1814538T1 (sl) * 2004-11-24 2010-01-29 Alcon Inc Postopek dovajanje nosnega pršila
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US8101654B2 (en) 2005-07-08 2012-01-24 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
CN101553206B (zh) * 2006-11-09 2012-11-21 爱尔康研究有限公司 用于药物递送的水不溶性聚合物基质
MX2009006146A (es) * 2006-12-18 2009-06-19 Alcon Res Ltd Dispositivos y metodos para la administracion de farmacos oftalmicos.
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
CN101621989A (zh) * 2007-02-07 2010-01-06 爱尔康公司 用于局部鼻施用的奥洛他定制剂
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
MX2009010946A (es) * 2007-04-11 2009-10-29 Alcon Res Ltd Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica.
WO2009031682A1 (ja) 2007-09-06 2009-03-12 Kyowa Hakko Kirin Co., Ltd. ジベンゾ[b,e]オキセピン誘導体含有点眼剤
BRPI0912985A2 (pt) * 2008-05-19 2015-10-13 Alcon Res Ltd composições farmacêuticas com polímero de carboxivinila e polímero de povidona
EP2318101A1 (en) * 2008-08-26 2011-05-11 Trutek Corp. Electrostatically charged mask filter products and method for increased filtration efficiency
JP2012509250A (ja) * 2008-08-28 2012-04-19 トルテック コーポレーション 抗ヒスタミン及び抗ヒスタミン様経鼻適用製品及び方法
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
BR112012001169A2 (pt) * 2009-07-17 2016-03-01 Alcon Res Ltd sistema de pulverização nasal de olopatadina para crianças
WO2011027322A1 (en) * 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US8551938B2 (en) * 2009-09-25 2013-10-08 Alcon Research, Ltd. NPR-B agonists
BR112012006579A2 (pt) 2009-09-25 2016-11-22 Alcon Res Ltd agonistas de npr-b.
AU2010300421B2 (en) * 2009-10-01 2014-01-23 Alcon Research, Ltd. Olopatadine compositions and uses thereof
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
JP2013535451A (ja) * 2010-07-21 2013-09-12 アルコン リサーチ, リミテッド 増強された溶解度特徴を有する薬学的組成物
CA2812164A1 (en) * 2010-11-08 2012-05-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠(olopatadine)眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
MA47418A (fr) 2017-02-01 2021-06-02 Takeda Pharmaceuticals Co Composés et compositions pour le traitement de troubles ophtalmiques
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
TW202133861A (zh) * 2019-12-06 2021-09-16 日商東興藥品工業股份有限公司 含有歐羅派特錠的點鼻用組成物
WO2021199814A1 (ja) * 2020-03-31 2021-10-07 参天製薬株式会社 樹脂製容器に充填された銀塩含有眼科用水性組成物
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
EP0316633B1 (de) * 1987-11-13 1993-01-27 ASTA Medica Aktiengesellschaft Azelastin enthaltende Arzneimittel zur Anwendung in der Nase und/oder am Auge
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
WO1998056381A1 (en) * 1997-06-09 1998-12-17 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
DE69900207T2 (de) 1998-07-14 2001-11-22 Alcon Laboratories, Inc. Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
PT1124535E (pt) * 1998-10-27 2003-04-30 Alcon Lab Inc Sistema conservante para composicoes farmaceuticas topicamente administraveis contendo um sabao de acido gordo/amino acido
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) * 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
TR200200724T2 (tr) 1999-09-21 2002-06-21 Alcon Laboratories, Inc. Cilde sürülebilen farmasötik bileşimlerin antimikrobik etkisinin arttırılması için yağlı asit/amino asit sabunlarının kullanımı
CN1376066A (zh) 1999-11-18 2002-10-23 爱尔康公司 H1拮抗剂和安全类固醇的治疗眼病的用途
DE60109742T2 (de) 2000-01-25 2005-08-18 Alcon Inc. Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP2006508138A (ja) 2002-11-12 2006-03-09 アルコン,インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用

Similar Documents

Publication Publication Date Title
JP2012107046A5 (OSRAM)
JP2010150292A5 (OSRAM)
JP2015500794A5 (OSRAM)
AR118582A2 (es) Procedimiento para producir sílice precipitada tratada
JP2004536096A5 (OSRAM)
MX2015009037A (es) Enjuague nasal con miel.
MX354456B (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
WO2019023564A8 (en) High concentration anti-c5 antibody formulations
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
MX360684B (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia.
EA201990616A3 (ru) Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
NZ607580A (en) N-heteroaryl compounds
EP4249431A3 (en) Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
RU2012103458A (ru) Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций
JP2019104727A5 (OSRAM)
EP2328550A4 (en) MUCOADHERENT COMPOSITIONS AND THEIR USE
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
MX357888B (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
JP2013529632A5 (OSRAM)
RU2010141793A (ru) Терапевтические замещенные циклопентаны
JP2012530146A5 (OSRAM)
RU2012114744A (ru) Способ получения пористых, пленочных материалов на основе карбоксиметилцеллюлозы